The effect of anti-thyroid antibodies positivity on children with primary immune thrombocytopenia

Primary immune thrombocytopenia (ITP) is the most common cause of acquired thrombocytopenia in children. Anti-thyroid antibodies (aTA) have previously been found to be present in various autoimmune diseases. Our aim was to study the effect of aTA positivity (which are anti-thyroid peroxidase (aTPo)...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric hematology and oncology 2017-07, Vol.34 (5), p.298-307
Main Authors: Mousa, Suzan O., Soliman, Gamal T., Saedii, Ahmed A.-F., Hameed, Emad N.
Format: Article
Language:English
Subjects:
anti-thyroglobulin antibody
anti-thyroid peroxidase antibody
Autoantibodies - blood
Case-Control Studies
Child
Child, Preschool
Female
Humans
immune thrombocytopenia
Immunoglobulins, Intravenous - administration & dosage
Infant
Male
Methylprednisolone - administration & dosage
Platelet Count
Purpura, Thrombocytopenic, Idiopathic - blood
Purpura, Thrombocytopenic, Idiopathic - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Primary immune thrombocytopenia (ITP) is the most common cause of acquired thrombocytopenia in children. Anti-thyroid antibodies (aTA) have previously been found to be present in various autoimmune diseases. Our aim was to study the effect of aTA positivity (which are anti-thyroid peroxidase (aTPo) and/or anti-thyroglobulin (aTg)) on children with primary immune thrombocytopenia and their relation to treatment response. Sixty-one children with primary ITP were enrolled in the present study. They were further subdivided into: ND&P group (newly diagnosed and persistent) and chronic ITP group. Seventy-five apparently healthy children were enrolled as control group. aTPo and aTg antibodies were significantly higher and more frequently positive in all children with ITP and in each ITP group than the control group (P .05). aTA positive children with ITP had significantly lower platelet count: at the start of treatment (P =.009), after receiving methylprednisolone or intravenous immunoglobulin (P =.02) and at one month follow-up (P =.003) than aTA negative children with ITP. Lastly, aTA positive children had more relapses (P =.03), continued more frequently to have relapses after one year in the ND&P group (P =.02) and required immunosuppressive therapy more frequently in the chronic ITP group (P =.005).
ISSN:0888-0018
1521-0669
DOI:10.1080/08880018.2017.1400136